Global Genotyping Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2026
MarketResearch.biz delivers in-depth insights on the global Genotyping market in its upcoming report titled, “Global Genotyping Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global Genotyping market is estimated to register a CAGR of XX.X% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2026. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global genotyping market report has been segmented on the basis of product, technology, application, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
The process of studying DNA sequence in order to determine the genetic constitution in genotypes of living organisms, such as animals, humans, plants, and microorganisms using biological assays is called as genotyping.
Increasing prevalence of genetic diseases and increasing demand for personalized medicines are major factors driving growth of the global genotyping market. In addition, rising importance of SNP Genotyping for drug development process is another factor expected to further propel growth of the global market to a significant extent over the forecast period. Moreover, rising demand for genome analysis in plant and animal livestock is another factor propelling growth of the global market.
Specific primers required for genotyping can be expensive and lack of skilled professionals in developing and underdeveloped countries are major factors hampering growth of the global genotyping market. In addition, sometimes exact genotyping is not possible, this is another factor hampering growth of the global market. However, technological advancements towards development of advanced and efficient procedures for genotyping is a factor expected to create lucrative opportunities for key players in the global market over the forecast period.
The North America market accounts for highest share in the global genotyping market in terms of revenue and is expected to maintain its dominance over the forecast period. Presence of major players, early adoption of this technology, and developed healthcare infrastructure are major factors driving growth of the North America genotyping market. The Europe market accounts for considerable share in terms of revenue in the global market. The Europe genotyping market is expected to witness significant growth and is expected to register a CAGR of X.X% over the forecast period. The Asia Pacific genotyping market is expected to witness highest growth in the global market and is projected to register a CAGR of XX.X% over the next 10 years. Increasing healthcare expenditure and increasing number of hospitals and clinical laboratories are major factors driving growth of the Asia Pacific genotyping market.
Global genotyping market segmentation:
Segmentation on the basis of product:
- Reagents & Kits
- Genotyping Services
Segmentation on the basis of technology:
- Polymerase Chain Reaction(PCR)
- Capillary electrophoresis
- Mass spectrometry
Segmentation on the basis of application:
- Drug discovery and development
- Personalized medicine
- Academic research
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- Affymetrix, Inc.
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Beckman Coulter
- Sequenom, Inc.
- Fluidigm Corporation
- Agilent Technologies, Inc.
- Genewiz, Inc.
- Fludigm Corporation
- GE Healthcare GmbH
- Qiagen NV
- Roche Diagnostics
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!